HHV-6 University

Hundreds of coronavirus patients have joined a new 'bootcamp' aimed at treating their lingering symptoms Source: Business Insider https://www.businessinsider.com/coronavirus-bootcamp-long-haulers-treatment-lingering-symptoms-2020-8

https://www.thehindubusinessline.com/news/science/study-finds-how-covid-19-kills-offering-possible-ways-to-stop-the-pandemic/article32463209.ece

"The COVID-19 pandemic has prompted a flurry of scientific studies of various potential treatments and vaccines for the novel coronavirus. One such study, conducted by researchers at Rensselaer Polytechnic Institute and published in Antiviral Research, showed the FDA-approved anticoagulant heparin may neutralize SARS-CoV-2, the virus that causes COVID-19." https://www.healio.com/news/hematology-oncology/20200827/heparin-may-neutralize-virus-that-causes-covid19

OCALA, FL / ACCESSWIRE / August 27, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM) is pleased to announce that it has identified an effective in vitro model at The Institute for Antiviral Research at Utah State University for testing Ampligen, a dsRNA TLR3 agonist, and the results show that Ampligen was able to decrease SARS-CoV-2 infectious viral yields by 90% at clinically achievable intranasal Ampligen dosage levels. This result supports AIM's goal of developing an intranasal prophylactic approach using Ampligen to prevent COVID-19. "We are pleased with these results, as they establish Ampligen's bio-activity against SARS-CoV-2 as well as support our decision to test Ampligen in humans as an intranasal prophylaxis and early-onset therapy against COVID-19," said AIM CEO Thomas K. Equels. The 3D-mucociliary tissue culture of normal, human-derived tracheal/bronchial epithelial cells sufficiently models some of the key innate immune responses needed

Genomic analysis reveals many animal species may be vulnerable to SARS-CoV-2 infection By Lisa Howard, UC Davis "About 40 percent of the species potentially susceptible to SARS-CoV-2 are classified as "threatened" by the International Union for Conservation of Nature and may be especially vulnerable to human-to-animal transmission. The study was published Aug. 21 in the Proceedings of the National Academy of Sciences ." https://medicalxpress.com/news/2020-08-genomic-analysis-reveals-animal-species.html The study: Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates "The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of COVID-19, a major pandemic that threatens millions of human lives and the global economy. We identified a large number of mammals that can potentially be infected by SARS-CoV-2 via their ACE2 proteins. This can assist the identification of intermedia

Chronic Fatigue Syndrome, Viruses, and the Innate Immune System  Theodore Henderson, MD, PhD https://www.psychiatryadvisor.com/home/topics/general-psychiatry/chronic-fatigue-syndrome-viruses-and-the-innate-immune-system/

Good news for COVID-19 Long Haulers and CFS patients: after a long wait and extensive preparations, today we started our first set of experiments to see if COVID-19 has a direct effect on mitochondria and if HHV-6 is a potential mediator in this process. Fingers crossed. — Bhupesh K Prusty (@BhupeshPrusty) August 20, 2020 Thanks to Bhupesh Prusty, the search for the cause of Chronic Fatigue Syndrome may soon be over. Has Bhupesh Prusty found a promising treatment for HHV-6 and Chronic Fatigue Syndrome? The Chronic Fatigue Syndrome and HHV-6 Scientist of the Year  Dr. Bhupesh Prusty and Professor Thomas Rudel discuss their HHV-6 research Will Bhupesh Prusty add more evidence that HHV-6 is the cause of Chronic Fatigue Syndrome? "Bhupesh Prusty is determining if HHV-6 infections are hampering mitochondrial functioning in ME/CFS." Chronic Fatigue Syndrome activist's 2018 research summary leaves out HHV-6 and the work of Bhupesh Prusty The Chronic Fa

MEA Summary Review: Is mystery factor in plasma causing viral immunity in ME/CFS? https://meassociation.org.uk/2020/05/mea-summary-review-is-mystery-factor-in-plasma-causing-viral-immunity-in-me-cfs-06-may-2020/

Source: https://www.motherjones.com/food/2020/08/industrial-hog-farms-are-breeding-the-next-pandemic/

The Corona Triangle Part II: Technical Report Immo Fiebrig • Larissa Bombardi • Pablo Nepomuceno     Introduction Within the last three months, the international press has reported several cases of slaughterhouse workers infected with COVID-19. According to the news, many of these slaughterhouses seem to be some sort of super-spreading hot spot. Three countries - the United States, Germany and Brazil - drew the attention of the authors, because of their own nationalities and/or because of the representation that these countries have in the world’s production and export of pork. These countries will therefore be the focus of this report. In terms of the ranking in world pig production1, China ranks first, followed by the United States and the European Union with Brazil coming fourth. Amongst EU countries, Germany ranks first and slaughters 23% of the EU total of pigs2. In these three countries of focus, there has been a considerable amount of complaint involving cases of slaughter

https://www.mdpi.com/2077-0383/9/8/2443/htm

https://www.startribune.com/university-of-minnesota-turns-natural-killer-cells-against-covid-19/572029642/?ref=nl&om_rid=3520749001&om_mid=979813833

"I don’t know if chloroquine (HCQ) is effective against COVID. It’s disturbing that I, like many other Americans feel that we won’t learn the truth from Dr Fauci. A 2005 Virology Journal article by MJ Vincent & CDC’s Eric Bergeron et al, surfaced this week. The study concludes: “We report...that chloroquine has strong antiviral effects on SARS-Coronavirus infection of primate cells. These inhibitory effects are observed when the cells are treated with the drug either before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage.” This conclusion implies that chloroquine functions both as a preventative “vaccine” and as a cure for strains of coronavirus. If these results persist in human models in COVID 19, as last week’s Michigan hospital study and abundant evidence from US doctors and other nations suggest—HCQ might compete with Dr Fauci’s vaccines including the Moderna vaccine for which his agency owns half the patent and Dr Fauci has inv